Extensive cytoreductive surgery in stage IV ovarian cancer may not be a justified treatment strategy
The implementation of a very high surgical proficiency setting was not associated with improved survival in patients with stage IV despite complete macroscopic resection, as opposed to patients with stage III.
Authors
- Sahar Salehi (ORCID: https://orcid.org/0000-0002-5426-2570)
- Nina Groes Kofoed (ORCID: https://orcid.org/0000-0001-6565-1451)
- Matteo Bottai (ORCID: https://orcid.org/0000-0002-3531-2739)
- Ulrika Joneborg (ORCID: https://orcid.org/0000-0002-1922-0738)
- Henrik Falconer (ORCID: https://orcid.org/0000-0003-4427-9421)
Institutions
- Karolinska University Hospital (SE)
- Karolinska Institutet (SE)
Publication Details
- Journal
- European Journal of Surgical Oncology
- Published
- 2025-06-02
- DOI
- https://doi.org/10.1016/j.ejso.2025.110207
- Primary Topic
- Ovarian cancer diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00